Cargando…
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889095/ https://www.ncbi.nlm.nih.gov/pubmed/36736338 http://dx.doi.org/10.1016/S1473-3099(23)00051-8 |
| _version_ | 1784880661480341504 |
|---|---|
| author | Uriu, Keiya Ito, Jumpei Zahradnik, Jiri Fujita, Shigeru Kosugi, Yusuke Schreiber, Gideon Sato, Kei |
| author_facet | Uriu, Keiya Ito, Jumpei Zahradnik, Jiri Fujita, Shigeru Kosugi, Yusuke Schreiber, Gideon Sato, Kei |
| author_sort | Uriu, Keiya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9889095 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98890952023-02-01 Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant Uriu, Keiya Ito, Jumpei Zahradnik, Jiri Fujita, Shigeru Kosugi, Yusuke Schreiber, Gideon Sato, Kei Lancet Infect Dis Correspondence Elsevier Ltd. 2023-03 2023-01-31 /pmc/articles/PMC9889095/ /pubmed/36736338 http://dx.doi.org/10.1016/S1473-3099(23)00051-8 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Uriu, Keiya Ito, Jumpei Zahradnik, Jiri Fujita, Shigeru Kosugi, Yusuke Schreiber, Gideon Sato, Kei Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant |
| title | Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant |
| title_full | Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant |
| title_fullStr | Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant |
| title_full_unstemmed | Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant |
| title_short | Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant |
| title_sort | enhanced transmissibility, infectivity, and immune resistance of the sars-cov-2 omicron xbb.1.5 variant |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889095/ https://www.ncbi.nlm.nih.gov/pubmed/36736338 http://dx.doi.org/10.1016/S1473-3099(23)00051-8 |
| work_keys_str_mv | AT uriukeiya enhancedtransmissibilityinfectivityandimmuneresistanceofthesarscov2omicronxbb15variant AT itojumpei enhancedtransmissibilityinfectivityandimmuneresistanceofthesarscov2omicronxbb15variant AT zahradnikjiri enhancedtransmissibilityinfectivityandimmuneresistanceofthesarscov2omicronxbb15variant AT fujitashigeru enhancedtransmissibilityinfectivityandimmuneresistanceofthesarscov2omicronxbb15variant AT kosugiyusuke enhancedtransmissibilityinfectivityandimmuneresistanceofthesarscov2omicronxbb15variant AT schreibergideon enhancedtransmissibilityinfectivityandimmuneresistanceofthesarscov2omicronxbb15variant AT enhancedtransmissibilityinfectivityandimmuneresistanceofthesarscov2omicronxbb15variant AT satokei enhancedtransmissibilityinfectivityandimmuneresistanceofthesarscov2omicronxbb15variant |